Subspecialization in Oncology Increasingly Utilized

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

MONDAY, Aug. 11, 2025 -- Subspecialization in oncology is increasing, but varies widely across cancer types and regions, according to a study published online Aug. 12 in the Annals of Internal Medicine.

Rene Karadakic, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues conducted a retrospective cohort study using Medicare claims data from 2007 to 2021 to quantify trends in oncologist subspecialized cancer care in the United States. Subspecialization was identified if oncologists managed more than 80 percent of chemotherapy episodes within a single cancer category.

The researchers found that from 2008 to 2020, there was an increase in the proportion of episodes managed by subspecialists, from 9 to 18 percent, among 18,633 oncologists and 9.25 million chemotherapy episodes. Across cancer types and regions, there was wide variation in utilization, with the highest levels seen in large metropolitan areas. Over time, differences by income widened: In 2020, 27.6 and 8.8 percent of episodes were managed by subspecialists in the highest-income and the lowest-income counties, respectively, despite higher cancer mortality in the latter.

"If patients of subspecialists receive more guideline-recommended care or have better outcomes, a critical question that requires further investigation, then targeted policies may be needed to address differences in utilization of subspecialized care," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-12 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords